Women’s Health Initiative study netted $37 billion in savingsMay 5, 2014MenopauseGynecologyPreventive Care
Yearly monitoring does not predict fractures after bisphosphonate cessationMay 5, 2014OsteoporosisMenopause
Topical lidocaine reduces menopausal dyspareuniaApril 25, 2014Breast CancerGynecologyMenopauseGynecologic Cancer
No survival benefit to bisphosphonate in chemoresistant breast cancerDecember 16, 2013MenopauseOsteoporosisBreast Cancer
Hormone therapy’s protection against endometrial cancer persists in Women’s Health Initiative follow-up studyOctober 25, 2013Reproductive EndocrinologyGynecologic CancerGynecologyMenopause
In the hormone therapy fight, bioidenticals come out swinging October 18, 2013MenopauseReproductive Endocrinology
